Dr John Fanaras, PHARMD - Pharmacist in Bedford, NH

Dr John Fanaras, PHARMD is a Pharmacist based in Bedford, New Hampshire. Dr John Fanaras is licensed to practice in New Hampshire (license number 4500) and his current practice location is 209 Route 101, Bedford, New Hampshire. He can be reached at his office (for appointments etc.) via phone at (603) 496-4815.

NPI number for Dr John Fanaras is 1598225500 and his current mailing address is 3 Longview Dr, Bow, New Hampshire. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1598225500.

Contact Information

Dr John Fanaras, PHARMD
209 Route 101,
Bedford, NH 03110-5440
(603) 496-4815
Not Available

Healthcare Provider's Profile

Full NameDr John Fanaras
GenderMale
SpecialityPharmacist
Location209 Route 101, Bedford, New Hampshire
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1598225500
  • Provider Enumeration Date: 03/25/2019
  • Last Update Date: 03/25/2019

Medical Identifiers

Medical identifiers for Dr John Fanaras such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1598225500NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 4500 (New Hampshire)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John Fanaras is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr John Fanaras, PHARMD
3 Longview Dr,
Bow, NH 03304-4809

Ph: (603) 496-4815
Dr John Fanaras, PHARMD
209 Route 101,
Bedford, NH 03110-5440

Ph: (603) 496-4815

News Archive

Gene editing technique helps uncover potential new drug targets for KRAS-driven cancers

Cancers driven by mutations in the KRAS gene are among the most deadly. For decades, researchers have tried unsuccessfully to directly target mutant KRAS proteins as a means to treat tumors.

Watson Pharmaceuticals announces third quarter 2009 financial results

Watson Pharmaceuticals, Inc. today reported net income of $63.0 million, or $0.55 per diluted share for the third quarter ended September 30, 2009. Excluding special items as detailed in the reconciliation table below, adjusted net income for the third quarter was $76.1 million, or $0.66 per diluted share, an increase of $22.1 million or 41 percent over the adjusted net income for the third quarter ended September 30, 2008. As detailed in the attached reconciliation table, adjusted EBITDA for the third quarter was $178.4 million.

Nanoscopic findings may lead to new experimental methods for early multiple sclerosis diagnosis

Laboratory studies by chemical engineers at UC Santa Barbara may lead to new experimental methods for early detection and diagnosis - and to possible treatments - for pathological tissues that are precursors to multiple sclerosis and similar diseases.

Global experts develop open-source N95 face mask

In one of the latest COVID-19 response projects at the University of Massachusetts Amherst, the Advanced Digital Design and Fabrication laboratory is collaborating with a global network of design, engineering and manufacturing experts to help develop an open-source N95 face mask.

Vaping among teens doubles in a year says MTF report

The 45th Monitoring the Future (MTF) survey 2019 has revealed that teenagers are preferring e cigarettes more and more and there is an increased propensity of using nicotine and marijuana in their e cigarettes. The latest report titled, "Trends in Reported Marijuana Vaping among U.S. Adolescents, 2017-2019", was released in the current issue of the Journal of the American Medical Association.

Read more News

› Verified 9 days ago


Pharmacist in Bedford, NH

Dr. Falon Anne Kaspszak, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 209 Route 101, Bedford, NH 03110
Phone: 603-472-3919    Fax: 603-472-7448
Kim Ahearn, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 209 Route 101, Bedford, NH 03110
Phone: 603-472-3919    Fax: 603-472-7448
Laurie Keith, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 258 Wallace Rd, Bedford, NH 03110
Phone: 603-472-5847    
Nicholas Driscoll,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 258 Wallace Rd, Bedford, NH 03110
Phone: 603-472-5847    
Mrs. Ronda Lee Hatin, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 5 Colby Ct, Bedford, NH 03110
Phone: 603-622-2320    
Mrs. Lori Ellen Connors, PHARM D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 220 S River Rd, Bedford, NH 03110
Phone: 603-263-0062    
Ms. Narmin Pirmohamed, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 8 Technology Dr, Bedford, NH 03110
Phone: 603-626-6200    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.